Clinical Trials Browser

Phase 1/2 × Completed × nimotuzumab × Clear all

NCT05278728 2025-02-07

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT02095119 2015-04-14

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Phase 1/2 Completed

Uterine Cervical Neoplasms